Publications by authors named "Kayo Yuminoki"

Claim this Profile
E
Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology.
Yoshiki Kojo, Hiroki Suzuki, Kouki Kato, Yuuki Kaneko, Kayo Yuminoki

Int J Pharm· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel nanoparticle formulation of thymoquinone with a cold wet-milling system and its pharmacokinetic analysis.
Takuya Nihei, Hiroki Suzuki, Asako Aoki, Kayo Yuminoki, Naofumi Hashimoto

Int J Pharm· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability.
Masanori Ochi, Keisuke Kimura, Atsushi Kanda, Takaki Kawachi, Akitoshi Matsuda, Kayo Yuminoki

AAPS PharmSciTech· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic application of self-micellizing solid dispersion technology to respirable powder formulation of tranilast for improved therapeutic potential.
Hiroki Suzuki, Yoshiki Kojo, Keisuke Yakushiji, Kayo Yuminoki, Naofumi Hashimoto

Int J Pharm· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
Kayo Yuminoki, Fuko Seko, Shota Horii, Haruka Takeuchi, Katsuya Teramoto

J Pharm Sci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability.
Satomi Onoue, Hiroki Suzuki, Yoshiki Kojo, Saori Matsunaga, Hideyuki Sato, Kayo Yuminoki

Eur J Pharm Sci· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors.
Masanori Ochi, Takaki Kawachi, Eri Toita, Issei Hashimoto, Kayo Yuminoki

Int J Pharm· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Equivalence studies of pravastatin original and generic drugs by dissolution test].
Takao Nakauchi, Ena Takeuchi, Takuya Okamoto, Katsuya Teramoto, Aoi Nozaki, Kayo Yuminoki

Yakugaku Zasshi· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wet-milling system.
Satomi Onoue, Naohiko Terasawa, Tatsuya Nakamura, Kayo Yuminoki, Naofumi Hashimoto

Eur J Pharm Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel solid dispersion of tranilast using amphiphilic block copolymer for improved oral bioavailability.
Satomi Onoue, Yoshiki Kojo, Hiroki Suzuki, Kayo Yuminoki, Keitatsu Kou

Int J Pharm· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
Satomi Onoue, Tatsuya Nakamura, Atsushi Uchida, Kazunori Ogawa, Kayo Yuminoki

Eur J Pharm Sci· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative studies on physicochemical stability of cyclosporine A-loaded amorphous solid dispersions.
Hideyuki Sato, Yohei Kawabata, Kayo Yuminoki, Naofumi Hashimoto, Yukinori Yamauchi

Int J Pharm· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of high-energy amorphous solid dispersion of nanosized nobiletin, a citrus polymethoxylated flavone, with improved oral bioavailability.
Satomi Onoue, Atsushi Uchida, Haruki Takahashi, Yoshiki Seto, Yohei Kawabata, Kayo Yuminoki

J Pharm Sci· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.
Satomi Onoue, Hideyuki Sato, Kumiko Ogawa, Yohei Kawabata, Takahiro Mizumoto, Kayo Yuminoki

Int J Pharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanosizing of poorly water soluble compounds using rotation/revolution mixer.
Takayuki Takatsuka, Tomoko Endo, Yao Jianguo, Kayo Yuminoki, Naofumi Hashimoto

Chem Pharm Bull (Tokyo)· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis